z-logo
open-access-imgOpen Access
ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety
Author(s) -
Alison B. Kohan,
Fei Wang,
Chunmin C. Lo,
Min Liu,
Patrick Tso
Publication year - 2015
Publication title -
ajp gastrointestinal and liver physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.644
H-Index - 169
eISSN - 1522-1547
pISSN - 0193-1857
DOI - 10.1152/ajpgi.00098.2014
Subject(s) - chylomicron , glucose homeostasis , lipid metabolism , endocrinology , homeostasis , medicine , energy homeostasis , small intestine , biology , carbohydrate metabolism , cholesterol , diabetes mellitus , chemistry , lipoprotein , insulin resistance , obesity , very low density lipoprotein
Apolipoprotein A-IV (apoA-IV) is secreted by the small intestine on chylomicrons into intestinal lymph in response to fat absorption. Many physiological functions have been ascribed to apoA-IV, including a role in chylomicron assembly and lipid metabolism, a mediator of reverse-cholesterol transport, an acute satiety factor, a regulator of gastric function, and, finally, a modulator of blood glucose homeostasis. The purpose of this review is to update our current view of intestinal apoA-IV synthesis and secretion and the physiological roles of apoA-IV in lipid metabolism and energy homeostasis, and to underscore the potential for intestinal apoA-IV to serve as a therapeutic target for the treatment of diabetes and obesity-related disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom